Hawk Ridge Capital Management LP Repligen Corp Transaction History
Hawk Ridge Capital Management LP
- $2.03 Billion
- Q2 2025
A detailed history of Hawk Ridge Capital Management LP transactions in Repligen Corp stock. As of the latest transaction made, Hawk Ridge Capital Management LP holds 115,400 shares of RGEN stock, worth $17.2 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
115,400Holding current value
$17.2 Million% of portfolio
0.71%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
504Shares Held
58.7MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.13 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$982 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$755 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$285 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$241 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.25B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....